TipRanks
Go Ultimate55% OFF

BATM Advanced Communications (BVC) AI Stock Analysis

IL:BVC

BATM Advanced Communications

(TASE:BVC)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Revenue growth re-acceleratedRevenue growth returned after modest increases in 2023 and 2024, then accelerated in 2025. This indicates improving commercial traction and provides a stronger base for operating leverage, reinvestment, and potential earnings recovery if growth can be sustained.
Negative Factors
Persistent net lossesBATM remains materially loss-making despite the year-on-year improvement in 2025. Persistent net losses weaken earnings quality, consume shareholder capital, and make it harder to fund growth internally, leaving the company dependent on a sustained operational turnaround.

BATM Advanced Communications (BVC) vs. iShares MSCI Israel ETF (EIS)

-40%-20%0%20%40%IL:BVC-36.46%EIS+13.14%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
ILS 38.34M
Dividend Yield
―
Average Volume (3M)
224.25K
Price to Earnings (P/E)
-4.0
Beta (1Y)
0.03
Revenue Growth
-2.18%
EPS Growth
39.02%
Country
Israel
Employees
867
Sector
Healthcare
Sector Strength
51
Industry
Medical - Instruments & Supplies

BATM Advanced Communications Business Overview & Revenue Model

Company Description

BATM Advanced Communications Ltd., together with its various group companies, delivers cutting-edge real-time technologies for both sophisticated networking solutions and advanced biomedical systems. The company operates across Israel, the United Sta...

BATM Advanced Communications Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

IL:BVC against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
GB:EKFGB:EKF64NeutralGBP 102.71M41.383.58%―2.26%-57.04%
GB:DXRXGB:DXRX59NeutralGBP 172.63M-635.94-0.68%―20.14%82.22%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
GB:ABDXGB:ABDX46NeutralGBP 22.75M-16.36-34.31%―30.42%43.16%
GB:CNSLGB:CNSL45NeutralGBP 3.69M-0.63-69.62%―-16.27%-471.21%
GB:RENXGB:RENX40UnderperformGBP 36.54M-3.44675.00%―――

* Healthcare Sector Average

Performance Comparison

-50%0%50%100%IL:BVCGB:EKFGB:CNSLGB:RENXGB:DXRXGB:ABDXDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
IL:BVC and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IL:BVCBATM Advanced Communications Ltd.46.70-27.30-36.89%
GB:EKFEKF Diagnostics Holdings24.00-2.20-8.40%
GB:CNSLOmega Diagnostics1.55-1.10-41.51%
GB:RENXRenalytix Plc OTC5.45-1.93-26.15%
GB:DXRXDiaceutics Plc203.5041.0025.23%
GB:ABDXAbingdon Health PLC9.002.7544.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.